2023
DOI: 10.3389/fimmu.2023.1141407
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a renal risk score for Japanese patients with ANCA-associated glomerulonephritis in a multi-center cohort study

Abstract: BackgroundIn patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis, prediction of renal survival should guide the choice of therapy, but a prediction of the histological classification has inconsistencies.ObjectivesTo evaluate the usefulness of renal risk score (RRS) for Japanese patients with ANCA-associated glomerulonephritis (AAGN) and compare the prediction for end-stage renal disease (ESRD) between RRS and the histological classification.MethodsWe retrospectively analyzed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 32 publications
0
4
0
Order By: Relevance
“… 15 Despite differences in patient characteristics, such as race and types of ANCA, the ARRS has been validated to better reflect renal prognosis compared with the glomerular classification proposed by Berden et al. 24 , 31 …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“… 15 Despite differences in patient characteristics, such as race and types of ANCA, the ARRS has been validated to better reflect renal prognosis compared with the glomerular classification proposed by Berden et al. 24 , 31 …”
Section: Discussionmentioning
confidence: 99%
“… 28 Regarding renal pathology, 3 nephrologists knowledgeable in the discipline reassessed and discussed glomerular, tubular, interstitial, and vascular lesions at the same time. 24 , 29 , 30 , 31 Regarding renal pathological findings, we referred to the report by Berden et al. and The Oxford classification of IgA nephropathy.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…There are some differences between our and other studies. Patients with renal-limited vasculitis, which accounts for around 20% of our cases, were not included in other studies [ 39 , 40 , 47 , 49 ]. In the cohort of An et al ., in comparison with our cohort, more patients were MPO-ANCA positive (88% vs 50.6% respectively), younger (57.5 vs 63.8 years), and with more recent and shorter period of enrollment (from 1997 to 2018 vs 1990 to 2022).…”
Section: Discussionmentioning
confidence: 99%